Eupraxia Pharmaceuticals Inc (EPRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 172 | 156 | 142 | 87 | 92 |
| Accounts receivable | -101 | -104 | 228 | 150 | 571 |
| Accounts payable and accrued liabilities | -715 | 578 | N/A | N/A | N/A |
| Other Working Capital | -6,765 | 5,352 | 1,527 | -166 | 1,223 |
| Other Operating Activity | -22,585 | -26,665 | -15,733 | -11,555 | -2,202 |
| Operating Cash Flow | $-29,994 | $-20,684 | $-13,835 | $-11,483 | $-317 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -75 | -73 | -227 | -339 | 64 |
| Purchase Of Investment | N/A | 0 | 0 | -7,059 | N/A |
| Sale Of Investment | N/A | 0 | 6,638 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -3,936 | -44 |
| Investing Cash Flow | $-75 | $-73 | $6,411 | $-11,333 | $19 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -9,075 | N/A | N/A | N/A | -784 |
| Debt Issued | N/A | N/A | 0 | 9,936 | 557 |
| Debt Repayment | -63 | -144 | -136 | -460 | -79 |
| Common Stock Issued | 54,559 | 15,887 | 9,798 | 29,673 | N/A |
| Other Financing Activity | 363 | 5,272 | 302 | 0 | -185 |
| Financing Cash Flow | $45,784 | $21,014 | $9,964 | $39,148 | $-491 |
| Exchange Rate Effect | -1,955 | 821 | 292 | -64 | N/A |
| Beginning Cash Position | 19,342 | 18,263 | 15,394 | 118 | 907 |
| End Cash Position | 33,101 | 19,342 | 18,226 | 16,386 | 118 |
| Net Cash Flow | $15,715 | $257 | $2,540 | $16,332 | $-789 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,994 | -20,684 | -13,835 | -11,483 | -317 |
| Capital Expenditure | -104 | -73 | -227 | -339 | N/A |
| Free Cash Flow | -30,099 | -20,757 | -14,062 | -11,822 | -317 |